Literature DB >> 11851901

Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection.

I K Kuramoto1, T Moriya, V Schoening, P V Holland.   

Abstract

The hepatitis C virus (HCV)-RNA levels were measured in 281 serum samples from 32 untreated volunteer blood donors prospectively collected over a period of 14-73 months. The HCV-RNA levels were tested by the branched DNA signal amplification assay. The mean HCV-RNA levels of each donor ranged from 4.92 log10-6.36 log10 gene equivalents/mL (25%, median, 75% percentile; 5.51, 5.79, 6.12 log10 gene equivalents/mL). The fluctuations of HCV-RNA levels in individuals, represented by the ratio of the maximum value divided by the minimum value, ranged from a 1.7- to a 141-fold change. Fluctuations with more than a 10-fold change were observed in five subjects: 11-, 15-, 17-, 96- and 141-fold changes. Eleven subjects were followed for at least 5 years; all subjects had fluctuations of HCV-RNA levels greater than 3-fold during the observation period. No blood donor was observed whose HCV levels changed from a high-level phase to a low-level phase or from low to high. No subjects cleared HCV during follow-up, although two had undetectable HCV-RNA levels transiently. These findings reveal that changes in HCV-RNA levels occur which are unrelated to treatment with interferon and ribavirin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851901     DOI: 10.1046/j.1365-2893.2002.00333.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users.

Authors:  Basmattee Boodram; Ronald C Hershow; Scott J Cotler; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

2.  Comparison of serial Hepatitis C virus detection in samples submitted through serology for reflex confirmation versus samples directly submitted for quantitation.

Authors:  Howard B Gale; D Robert Dufour; Nazia N Qazi; Virginia L Kan
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

3.  An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.

Authors:  Jonathan B Parr; Evans K Lodge; Vera Holzmayer; Jacques Pepin; Eric H Frost; Michael W Fried; David R McGivern; Stanley M Lemon; Corinna Keeler; Michael Emch; Kashamuka Mwandagalirwa; Antoinette Tshefu; Franck Fwamba; Jérémie Muwonga; Steven R Meshnick; Gavin Cloherty
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study.

Authors:  Jean-Luc Szpakowski; Lue-Yen Tucker; David M Baer; Mary Pat Pauly
Journal:  Can Liver J       Date:  2022-02-04

5.  Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis.

Authors:  John R Ticehurst; Fayez M Hamzeh; David L Thomas
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

6.  Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Authors:  Vicky M-H Sung; Shigetaka Shimodaira; Alison L Doughty; Gaston R Picchio; Huong Can; T S Benedict Yen; Karen L Lindsay; Alexandra M Levine; Michael M C Lai
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria.

Authors:  Barbara H McGovern; Christopher E Birch; Melinda J Bowen; Laura L Reyor; Ellen H Nagami; Raymond T Chung; Arthur Y Kim
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.